| Ablasyon/Ablation | 1 |
| Ac-225-DOTATATE/Ac-225-DOTATATE | 300 |
| Ac-225/Ac-225 | 300 |
| Adjuvan tedavi/Adjuvant treatment | 1 |
| Akciğer kanseri/Lung cancer | 146 |
| Akciğer/Lungs | 252 |
| Anti tiroglobulin antikoru/Antithyroglobulin anti-body | 63 |
| Anti-tiroglobulin/Anti-thyroglobulin | 55 |
| Baş boyun tümörleri/Ead and neck tumors | 139 |
| Bilgisayarlı tomografi/Computerized tomography | 278 |
| Çocuk/Children | 187 |
| Diferansiye tiroid kanseri/Differentiated thyroid cancer | 47, 63, 93 |
| Diferansiye tiroid kanseri/Differentiated thyroid carcinoma | 1 |
| Dozimetri yönetmeliği/Regulations for dozimetry | 310 |
| Endometrium kanseri/Endometrial cancer | 166 |
| Enoskopik polipektomi/Endoscopic polypectomy | 263 |
| Exendin-4/Exendin-4 | 331 |
| F-18 DOPA/F-18 DOPA | 80 |
| F-18 FDG PET/BT/F-18 FDG PET/CT | 177 |
| F-18 FDG/F-18 FDG | 80 |
| FDG PET/BT/FDG PET/CT | 146 |
| FDG PET/BT/FDG PET/CT | 241 |
| FDG/FDG | 139 |
| Feokromasitoma/Pheochromocytoma | 293 |
| Ga-68 DOTATATE PET/Ga-68 DOTATATE PET | 236 |
| Ga-68 DOTATATE/Ga-68 DOTATATE | 80, 293 |
| Ga-68 PSMA-PET/ BT/Ga-68 PSMA-PET/CT | 246 |
| Gastrik tümör/Gastric tumors | 263 |
| Gastrointestinal/Gastrointestinal | 252 |
| GIP/GIP | 331 |
| GLP-1R/GLP-1R | 331 |
| Grad 3/Grade | 274 |
| Hastaya özel dozimetri/Patient-specific dosimetry | 310 |
| Hedefe yönelik tedaviler/Targeted therapies | 270 |
| I-123/I-123 | 70 |
| I-131 tedavisi/I-131 treatment | 1 |
| I-131/I-131 | 70 |
| İmmünoterapi/Immunotherapy | 196 |
| İnterferans/Interference | 55 |
| İyi diferansiye tiroid kanseri/Well differentiated thyroid cancer | 122 |
| İyi diferansiye tiroid kanserleri/Differentiated thyroid | |
| cancers | 55 |
| Kanser/Cancer | 187, 196 |
| Karsinoid kriz/Carcinoid crisis | 316 |
| Kolorektal kanser/Colorectal carcinoma | 241 |
| Kontrastlı bilgisayarlı tomografi/Contrast-enhanced computed tomography | 80 |
| Kromogranin A/Chromogranin A | 316 |
| Lenf nodu metastazı/Lymph nodes metastasis | 93 |
| Lenfoma/Lymphoma | 177 |
| Levotiroksin/Levothyroxine | 33 |
| Lu-177 dozimetri/Lu-177 dosimetry | 310 |
| Lu-177-DOTATATE/Lu-177-DOTATATE | 300 |
| Malignite/Malignancy | 187 |
| Manyetik rezonans görüntüleme/Magnetic resonance imaging | 80 |
| Manyetik rezonans/Magnetic resonance | 278 |
| Meme kanseri/Breast cancer | 157 |
| Metastatik nöroendokrin tümör/Metastatic neuroendocrine tumor | 270 |
| Minigastrin/Minigastrin | 331 |
| Neden dozimetri/Why dosimetry | 310 |
| Nöroendokrin karsinom/Neuroendocrine carcinoma | 252, 274 |
| Nöroendokrin neoplazileri/Neuroendocrine neoplasms | 331 |
| Nöroendokrin tümör/Neuroendocrine tumor | 236, 274, 278, 285, 300, 316 |
| Nöroendokrin tümör/Neuroendocrine tumors | 263, 326 |
| Nöroendokrin tümör/Neuroendocrine tumour | 252 |
| Oktreotid/Octreotide | 300, 316 |
| Onkoloji/Oncology | 220 |
| Over kanseri/Ovarian cancer | 166 |
| Pankreas/Pancreas | 252 |
| Paragangliomalarda/Paragangliomas | 293 |
| Pediatri/Pediatrics | 122 |
| Pediatrik/Pediatric | 187 |
| Peptid reseptör radyonüklit tedavi/Peptide receptor | |
| radionuclide therapy | 293 |
| PET/BT/PET/CT | 139, 157, 166, 187, 196 |
| PET/MR/PET/MRI | 220 |
| PET/PET | 285 |
| Pozitron emisyon tomografi/Positron emission | |
| tomography | 132, 212 |
| Pozitron emisyon tomografisi/Positron emission tomography | 80 |
| Prostat kanseri/Prostate cancer | 246 |
| PRRT/PRRT | 300 |
| PSMA/PSMA | 246 |
| Radyoaktif iyot tedavisi/Radioactive iodine treatment | 47 |
| Radyoaktif iyot/Radioactive iodine | 70 |
| Radyoembolizasyon/Radioembolization | 326 |
| Radyoiyot tedavisi/Radioiodine treatment | 101 |
| Radyoiyot/Radioiodine | 113 |
| Radyolojik görüntüleme/Radiologic imaging | 278 |
| Radyonüklit görüntüleme/Radionuclide imaging | 70 |
| Radyoterapi/Radiotherapy | 212 |
| Rekürrens/Recurrence | 93 |
| rTSH/rTSH | 113 |
| Serviks kanseri/Cervical cancer | 166 |
| Somatostatin analogları/Somatostatin analogs | 270 |
| Somatostatin reseptör antagonistleri/Somatostatin receptor antagonists | 331 |
| Somatostatin/Somatostatine | 285 |
| SPECT/SPECT | 285 |
| Standardizasyon/Standardization | 132 |
| TARE/TARE | 326 |
| Tedavi cevabı/Therapy response | 246 |
| Tedavi yanıt/Treatment response | 241 |
| Tedavi yanıtı/Response to therapy | 132 |
| Tedavi yanıtı/Therapy response | 236 |
| Tedavi yanıtı/Treatment response | 139, 146, 177, 187, 196, 220 |
| Tedavi yanıtının değerlendirilmesi/Treatment response evaluation | 157 |
| Tedavi/Therapy | 122 |
| Tedaviye yanıt/Treatment response | 212 |
| Tedaviye yanıtı değerlendirme/Treatment response evaluation | 166 |
| Teranostik/Theranostic | 293 |
| Teranostik/Theranostics | 300 |
| Tiroglobulin/Thyroglobulin | 47, 63, 113 |
| Tiroid kanseri/Thyroid cancer | 33, 70, 80, 113 |
| Tiroid/Thyroid | 101 |
| Tirotropin supresyonu/Thyrotropin suppression | 33 |
| Vulva-vajen kanseri/Vulva-vaginal cancer | 166 |
| Yan etkiler/Adverse effects | 101 |
| Yttrium-90/Yttrium-90 | 326 |